Valuation: Simulations Plus, Inc.

Market Cap 37Cr 33Cr 30Cr 28Cr 52Cr 3.55TCr 54Cr 360.56Cr 141.01Cr 1.76TCr 139.19Cr 136.17Cr 6.07TCr P/E 2026 *
43.6x
P/E 2027 * 40.1x
Enterprise Value 37Cr 33Cr 30Cr 28Cr 52Cr 3.55TCr 54Cr 360.56Cr 141.01Cr 1.76TCr 139.19Cr 136.17Cr 6.07TCr EV / Sales 2026 *
4.53x
EV / Sales 2027 * 4.3x
Free-Float
83.08%
Yield 2026 *
-
Yield 2027 * -
1 week+0.44%
Current month+0.11%
1 month-0.27%
3 months+31.02%
6 months+3.50%
Current year+0.55%
1 week 18.3
Extreme 18.3002
18.39
1 month 18.19
Extreme 18.19
18.5
Current year 11.09
Extreme 11.09
21.01
1 year 11.09
Extreme 11.09
21.01
3 years 11.09
Extreme 11.09
52.69
5 years 11.09
Extreme 11.09
67.59
10 years 7.9
Extreme 7.9
90.92
Manager TitleAgeSince
Chief Executive Officer 67 26/06/2018
Director of Finance/CFO 63 01/12/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 81 17/07/1996
Director/Board Member 58 03/12/2014
Chairman 76 17/12/2024
Date Insider Type Main position Quantity % Market Cap.
06/07/26 Sell

Executive/Senior Manager

-1,000 0.0050%
01/07/26 Sell

Founder

-4,177 0.0207%
16/06/26 Fiscal year

Executive/Senior Manager

22,050 0.1094%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.44%+36.08%-62.85% 37Cr
+3.33%+12.66%-27.62%+3.21% 3.38TCr
-1.98%-0.88%-49.75%+133.61% 1.19TCr
-0.25%+7.89%-24.25%+67.14% 561Cr
-2.15%+3.34% - - 215.95Cr
-3.83%+1.32%+39.79%-34.24% 188.28Cr
-0.46%-5.90% - - 167.68Cr
-0.30%-4.29%-36.25% - 101.79Cr
-2.72%-0.92%+30.00%+97.70% 85Cr
+0.89%+3.99%-41.95%-54.07% 78Cr
Average -0.74%+0.86%-9.24%+21.50% 599.77Cr
Weighted average by Cap. +1.22%+6.39%-28.76%+36.70%

Financials

2026 *2027 *
Net sales 8.19Cr 7.19Cr 6.72Cr 6.16Cr 12Cr 784.2Cr 12Cr 80Cr 31Cr 388.06Cr 31Cr 30Cr 1.34TCr 8.63Cr 7.58Cr 7.07Cr 6.49Cr 12Cr 826.21Cr 12Cr 84Cr 33Cr 408.84Cr 32Cr 32Cr 1.41TCr
Net income 95.34L 83.77L 78.2L 71.76L 1.34Cr 91Cr 1.38Cr 9.27Cr 3.63Cr 45Cr 3.58Cr 3.5Cr 156.21Cr 1.02Cr 89.46L 83.51L 76.64L 1.43Cr 98Cr 1.47Cr 9.9Cr 3.87Cr 48Cr 3.82Cr 3.74Cr 166.82Cr
Net Debt - -
Logo Simulations Plus, Inc.
Simulations Plus, Inc. specializes in model-informed and artificial intelligence (AI)-accelerated drug development. The Company helps its clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through science-based software and consulting solutions. The Company’s segments include Software and Services. The Company's Software segment supports pharmaceutical research, development, and commercialization through simulation, modeling, and AI-driven prediction. Its main products include GastroPlus, ADMET Predictor, MonolixSuite, and others for disease modeling and training, as well as Pro-ficiency for clinical operations. Its Services segment includes advanced consulting services across the entire drug development lifecycle. Its scientists and engineers specialize in drug discovery, pharmacokinetics, pharmacodynamics, drug modeling, clinical trial data analysis, regulatory strategy, and medical communications.
Employees
213
Date Price Change Volume
29/26/29 $18.33 0.00% 3,46,154
28/26/28 $18.33 0.00% 1,58,846
27/26/27 $18.33 -0.05% 3,91,624
24/26/24 $18.34 +0.05% 2,40,703
23/26/23 $18.33 +0.44% 5,71,006
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
18.33USD
Average target price
17.25USD
Spread / Average Target
-5.89%

Quarterly revenue - Rate of surprise